Both Merck and Pfizer are expected to report their Q2 '24 financial results on Tuesday morning, July 30 '24, before the opening bell. It's time for Pfizer to make hay after the pandemic spike, when th
Pfizer stock has fallen after a COVID-19 vaccine and treatment boost, but shares look attractive now. Enbridge produces predictable cash-flow growth and passes it on to investors with dividends.
24/7 Wall St. Insights Dividend stocks will outperform when the Federal Reserve starts to lower rates in September.
The market hasn't been kind to these companies. Pfizer just wrapped up a series of acquisitions and product launches, but these will take time to impact its balance sheet.
Pfizer yields 5.57% with a B- dividend safety rating, known for Eliquis and Xeljanz. Technical analysis tools show bullish trends: trading above 30-week EMA, increasing momentum, and improving relativ
Dividend yields have historically been a strong predictor of stock returns over long periods. Current market conditions could be ripe for a rally in high-yield equities.
These pandemic favorites may be down but don't yet count them out. Pfizer investors may be overreacting to its adjustments following the pandemic.
AstraZeneca is a healthcare giant trading at a discount. There's more to the story with Pfizer than its COVID woes and looming patent cliff.
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Will Pfizer Stock Post A Downbeat Q2?

10:00am, Friday, 26'th Jul 2024
Pfizer (NYSE: PFE) is scheduled to report its Q2 2024 results on Tuesday, July 30. We expect the company to post revenue of $12.95 billion and earnings of $0.44 on a per share and adjusted basis, lowe
High-yield dividend stocks can be complex to navigate. While dividend yields reduce investors' risk when the price dips, they also require investors to take on potentially more risk.

Pfizer's Q2 Focus: Core Products And New Ventures

03:30pm, Thursday, 25'th Jul 2024
Analysts predict Pfizer's Q2 2024 revenue to be around $13 billion​. The EPS estimate for Q2 2024 is $0.22, reflecting challenges from decreased COVID-19 product demand. Investors are closely watchi
The Investment Committee give you their top stocks to watch for the second half.
Get a deeper insight into the potential performance of Pfizer (PFE) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of
24/7 Insights Investors count on quality blue-chip companies to pay dependable dividends.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE